Does CAMRELIZUMAB Cause Off label use? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Off label use have been filed in association with CAMRELIZUMAB. This represents 12.1% of all adverse event reports for CAMRELIZUMAB.
52
Reports of Off label use with CAMRELIZUMAB
12.1%
of all CAMRELIZUMAB reports
15
Deaths
9
Hospitalizations
How Dangerous Is Off label use From CAMRELIZUMAB?
Of the 52 reports, 15 (28.8%) resulted in death, 9 (17.3%) required hospitalization, and 8 (15.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAMRELIZUMAB. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does CAMRELIZUMAB Cause?
Myelosuppression (70)
Fatigue (60)
Nausea (60)
Vomiting (59)
Diarrhoea (54)
Anaemia (53)
Hypothyroidism (53)
Rash (50)
Thrombocytopenia (46)
Reactive capillary endothelial proliferation (41)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CAMRELIZUMAB Alternatives Have Lower Off label use Risk?
CAMRELIZUMAB vs CANAGLIFLOZIN
CAMRELIZUMAB vs CANAGLIFLOZIN\METFORMIN
CAMRELIZUMAB vs CANAKINUMAB
CAMRELIZUMAB vs CANDESARTAN
CAMRELIZUMAB vs CANDESARTAN CILEXETIL